Jayson Bedford
Stock Analyst at Raymond James
(3.86)
# 638
Out of 4,944 analysts
318
Total ratings
54.82%
Success rate
7.07%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $101.82 | +10.98% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $110.32 | +63.16% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $84.76 | +20.34% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $80.17 | +27.23% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $102.64 | +20.81% | 26 | Jul 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $142 → $141 | $131.02 | +7.62% | 29 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $309.63 | +16.27% | 27 | May 27, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $150.13 | +23.23% | 7 | May 7, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $172.78 | -5.08% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $478.19 | +43.88% | 8 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $194.96 | +38.49% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $14.16 | -8.19% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $8.84 | +13.12% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $119.64 | +126.51% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.19 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.11 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $76.93 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.98 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $92.08 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.47 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $67.95 | +26.56% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.20 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.77 | - | 3 | Jan 2, 2018 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $101.82
Upside: +10.98%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $110.32
Upside: +63.16%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $84.76
Upside: +20.34%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $80.17
Upside: +27.23%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $102.64
Upside: +20.81%
Abbott Laboratories
Jul 18, 2025
Maintains: Outperform
Price Target: $142 → $141
Current: $131.02
Upside: +7.62%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $309.63
Upside: +16.27%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $150.13
Upside: +23.23%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $172.78
Upside: -5.08%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $478.19
Upside: +43.88%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $194.96
Upside: +38.49%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $14.16
Upside: -8.19%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $8.84
Upside: +13.12%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $119.64
Upside: +126.51%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.19
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $11.11
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $76.93
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $23.98
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $92.08
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.47
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $67.95
Upside: +26.56%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.20
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.77
Upside: -